Enantiomeric Separation of Tramadol and Its Metabolites: Method Validation and Application to Environmental Samples

The accurate assessment of racemic pharmaceuticals requires enantioselective analytical methods. This study presents the development and validation of an enantioselective liquid chromatography with a fluorescence detection method for the concomitant quantification of the enantiomers of tramadol and their metabolites, N-desmethyltramadol and O-desmethyltramadol, in wastewater samples. Optimized conditions were achieved using a Lux Cellulose-4 column 150 × 4.6 mm, 3 µm isocratic elution, and 0.1% diethylamine in hexane and ethanol (96:4, v/v) at 0.7 mL min−1. The samples were extracted using 150 mg Oasis® mixed-mode cation exchange (MCX) cartridges. The method was validated using a synthetic effluent of a laboratory-scale aerobic granular sludge sequencing batch reactor. The method demonstrated to be selective, accurate, and linear (r2 > 0.99) over the range of 56 ng L−1 to 392 ng L−1. The detection and the quantification limits of each enantiomer were 8 ng L−1 and 28 ng L−1 for tramadol and N-desmethyltramadol, and 20 ng L−1 and 56 ng L−1 for O-desmethyltramadol. The feasibility of the method was demonstrated in a screening study in influent and effluent samples from a wastewater treatment plant. The results demonstrated the occurrence of tramadol enantiomers up to 325.1 ng L−1 and 357.9 ng L−1, in the effluent and influent samples, respectively. Both metabolites were detected in influents and effluents.

[1]  F. Musshoff,et al.  Fatality due to ingestion of tramadol alone. , 2001, Forensic science international.

[2]  Alejandro J. Ramirez,et al.  Enantiospecific toxicity of the β‐blocker propranolol to Daphnia magna and Pimephales promelas , 2006, Environmental toxicology and chemistry.

[3]  D. Muntean,et al.  Optimized HPLC method for tramadol and O-desmethyl tramadol determination in human plasma. , 2008, Journal of biochemical and biophysical methods.

[4]  A. Lubben,et al.  Enantiomeric profiling of chiral drug biomarkers in wastewater with the usage of chiral liquid chromatography coupled with tandem mass spectrometry. , 2016, Journal of chromatography. A.

[5]  A. Foroumadi,et al.  Development and validation of a rapid HPLC method for simultaneous determination of tramadol, and its two main metabolites in human plasma. , 2006, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[6]  A. Foroumadi,et al.  Enantioselective determination of tramadol and its main phase I metabolites in human plasma by high-performance liquid chromatography. , 2008, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[7]  P. Shrivastav,et al.  An accurate, rapid and sensitive determination of tramadol and its active metabolite O-desmethyltramadol in human plasma by LC-MS/MS. , 2009, Journal of pharmaceutical and biomedical analysis.

[8]  H. El-Abhar,et al.  The effect of Nigella sativa oil against the liver damage induced by Schistosoma mansoni infection in mice. , 2002, Journal of ethnopharmacology.

[9]  P. Chiap,et al.  Automated determination of tramadol enantiomers in human plasma using solid-phase extraction in combination with chiral liquid chromatography. , 1997, Journal of chromatography. B, Biomedical sciences and applications.

[10]  M. Schmid,et al.  Chiral separation of cathinone derivatives used as recreational drugs by HPLC-UV using a CHIRALPAK® AS-H column as stationary phase. , 2012, Chirality.

[11]  J. Haginaka Recent progresses in protein-based chiral stationary phases for enantioseparations in liquid chromatography. , 2008, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[12]  G. Scriba Chiral Recognition Mechanisms in Analytical Separation Sciences , 2012, Chromatographia.

[13]  H. Dengler,et al.  PHARMACOKINETICS AND DISPOSITION , 1997 .

[14]  R. Raffa,et al.  Gas chromatographic method using nitrogen-phosphorus detection for the measurement of tramadol and its O-desmethyl metabolite in plasma and brain tissue of mice and rats. , 2001, Journal of chromatography. B, Biomedical sciences and applications.

[15]  S. Evans,et al.  Determination of chiral pharmaceuticals and illicit drugs in wastewater and sludge using microwave assisted extraction, solid-phase extraction and chiral liquid chromatography coupled with tandem mass spectrometry. , 2015, Analytica chimica acta.

[16]  T. C. Lourenço,et al.  Fases estacionárias quirais para cromatografia líquida de alta eficiência , 2010 .

[17]  P. Castro,et al.  Chiral pharmaceuticals in the environment , 2012, Environmental Chemistry Letters.

[18]  S. Grond,et al.  Clinical Pharmacology of Tramadol , 2004, Clinical pharmacokinetics.

[19]  D. Massart,et al.  Screening approach for chiral separation of pharmaceuticals. Part I. Normal-phase liquid chromatography. , 2002, Journal of chromatography. A.

[20]  R. Mehvar,et al.  Stereospecific high-performance liquid chromatographic analysis of tramadol and its O-demethylated (M1) and N,O-demethylated (M5) metabolites in human plasma. , 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[21]  F. Carvalho,et al.  Simultaneous quantification of tramadol and O-desmethyltramadol in hair samples by gas chromatography-electron impact/mass spectrometry. , 2013, Biomedical chromatography : BMC.

[22]  F. Musshoff,et al.  Enantiomeric determination of tramadol and O-desmethyltramadol by liquid chromatography- mass spectrometry and application to postoperative patients receiving tramadol. , 2006, Journal of analytical toxicology.

[23]  R. Calvo,et al.  Simultaneous determination of tramadol and its major active metabolite O-demethyltramadol by high-performance liquid chromatography with electrochemical detection. , 1999, Journal of chromatography. B, Biomedical sciences and applications.

[24]  L. Vlase,et al.  Determination of tramadol and O-desmethyltramadol in human plasma by high-performance liquid chromatography with mass spectrometry detection. , 2008, Talanta.

[25]  A. Hoeft,et al.  Concentrations of Tramadol and O‐desmethyltramadol Enantiomers in Different CYP2D6 Genotypes , 2007, Clinical pharmacology and therapeutics.

[26]  M. Pinto,et al.  Small Molecules as Chromatographic Tools for HPLC Enantiomeric Resolution: Pirkle-Type Chiral Stationary Phases Evolution , 2013, Chromatographia.

[27]  S. Gan,et al.  Validation of a high-performance liquid chromatography method for tramadol and o-desmethyltramadol in human plasma using solid-phase extraction. , 2001, Journal of chromatography. B, Biomedical sciences and applications.

[28]  T. Ward,et al.  Chiral separations: fundamental review 2010. , 2010, Analytical chemistry.

[29]  P. Castro,et al.  Environmental Fate of Chiral Pharmaceuticals: Determination, Degradation and Toxicity , 2012 .

[30]  Qin Li,et al.  Simultaneous analysis of tramadol, metoprolol and their metabolites in human plasma and urine by high performance liquid chromatography , 2006, Chinese medical journal.

[31]  J. Roeraade,et al.  Evaluation of generic chiral liquid chromatography screens for pharmaceutical analysis. , 2003, Journal of chromatography. A.

[32]  V. Sharma,et al.  Pharmaceuticals and personal care products in waters: occurrence, toxicity, and risk , 2015, Environmental Chemistry Letters.

[33]  M. Rouini,et al.  Improved liquid chromatographic method for the simultaneous determination of tramadol and its three main metabolites in human plasma, urine and saliva. , 2007, Journal of pharmaceutical and biomedical analysis.

[34]  S. Fanali,et al.  Simultaneous stereoselective analysis of tramadol and its main phase I metabolites by on-line capillary zone electrophoresis-electrospray ionization mass spectrometry. , 2000, Journal of chromatography. A.

[35]  Alejandro J. Ramirez,et al.  Enantiospecific sublethal effects of the antidepressant fluoxetine to a model aquatic vertebrate and invertebrate. , 2007, Chemosphere.

[36]  Y. Heyden,et al.  Screening approach for chiral separation of pharmaceuticals part II. Reversed-phase liquid chromatography. , 2002, Journal of chromatography. A.

[37]  Zhongqi Ren,et al.  Chiral liquid membrane for enantioselective separation of racemic ibuprofen by L-tartaric acid derivatives , 2015 .

[38]  Q. Cass,et al.  Enantiomeric resolution of a series of chiral sulfoxides by high-performance liquid chromatography on polysaccharide-based columns with multimodal elution. , 2003, Journal of chromatography. A.

[39]  A. R. Ribeiro,et al.  Enantioseparation of chiral pharmaceuticals in biomedical and environmental analyses by liquid chromatography: an overview. , 2014, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[40]  O. Matoušková,et al.  Enantiomeric determination of tramadol and O-desmethyltramadol in human plasma by fast liquid chromatographic technique coupled with mass spectrometric detection. , 2010, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[41]  M. Nobilis,et al.  High-performance liquid chromatographic determination of tramadol and its O-desmethylated metabolite in blood plasma. Application to a bioequivalence study in humans. , 2002, Journal of chromatography. A.

[42]  I. Rukhlenko,et al.  Completely Chiral Optical Force for Enantioseparation , 2016, Scientific Reports.

[43]  G. Szekely,et al.  Role of chirality and macroring in imprinted polymers with enantiodiscriminative power. , 2015, ACS applied materials & interfaces.

[44]  E. Tesařová,et al.  Recentchiral selectors for separation in HPLC and CE , 2012 .

[45]  E. Shipton,et al.  Pharmacokinetics of oral tramadol drops for postoperative pain relief in children aged 4 to 7 years--a pilot study. , 2002, Anesthesia progress.

[46]  F. Wong,et al.  The determination of RWJ-38705 (tramadol N-oxide) and its metabolites in preclinical pharmacokinetic studies using LC-MS/MS. , 2000, Journal of pharmaceutical and biomedical analysis.

[47]  J. P. Fawcett,et al.  Improved HPLC method for the simultaneous determination of tramadol and O-desmethyltramadol in human plasma. , 2005, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[48]  M. A. Campanero,et al.  Simultaneous stereoselective analysis of tramadol and its primary phase I metabolites in plasma by liquid chromatography. Application to a pharmacokinetic study in humans. , 2004, Journal of chromatography. A.

[49]  A. Ceccato,et al.  Enantiomeric determination of tramadol and its main metabolite O-desmethyltramadol in human plasma by liquid chromatography-tandem mass spectrometry. , 2000, Journal of chromatography. B, Biomedical sciences and applications.

[50]  A. Palmeira,et al.  Enantioresolution of chiral derivatives of xanthones on (S,S)-Whelk-O1 and L-phenylglycine stationary phases and chiral recognition mechanism by docking approach for (S,S)-Whelk-O1. , 2013, Chirality.

[51]  I. Moreira,et al.  Enantioselective quantification of fluoxetine and norfluoxetine by HPLC in wastewater effluents. , 2014, Chemosphere.

[52]  D. Holt,et al.  Simultaneous determination of tramadol, O-desmethyltramadol and N-desmethyltramadol in human urine by gas chromatography-mass spectrometry. , 2013, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[53]  E. Awadalla,et al.  Histopathological and Molecular Studies on Tramadol Mediated Hepato-Renal Toxicity in Rats , 2015 .

[54]  M. Lämmerhofer Chiral recognition by enantioselective liquid chromatography: mechanisms and modern chiral stationary phases. , 2010, Journal of chromatography. A.

[55]  K. Kümmerer,et al.  The significance of different health institutions and their respective contributions of active pharmaceutical ingredients to wastewater. , 2015, Environment international.

[56]  Y. Heyden,et al.  Screening approach for chiral separation of pharmaceuticals , 2002 .